10x Genomics (TXG) Shares Issued (2018 - 2026)

10x Genomics' Shares Issued history runs 9 years deep, the most recent figure standing at $273000.0 for Q1 2026.

• In Q1 2026, Shares Issued fell 35.31% year-over-year to $273000.0; the TTM figure through Mar 2026 stood at $6.7 million (down 31.39% YoY), while the FY2025 annual figure was $6.8 million, down 37.67% from the prior year.
• Shares Issued came in at $273000.0 for Q1 2026 at 10x Genomics, down from $2.2 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $7.8 million in Q1 2022 to a low of $156000.0 in Q3 2024.
• A 5-year average of $3.5 million and a median of $3.5 million in 2025 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued sank 96.43% in 2024 and surged 295.51% in 2025, its largest moves.
• 10x Genomics' Shares Issued stood at $5.0 million in 2022, then grew by 12.24% to $5.6 million in 2023, then declined by 19.53% to $4.5 million in 2024, then plunged by 50.37% to $2.2 million in 2025, then slumped by 87.82% to $273000.0 in 2026.
• According to Business Quant data, Shares Issued over the past three periods registered $273000.0, $2.2 million, and $617000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison